Successful pulmonary resection combined with chemotherapy for the treatment of Mycobacterium avium pulmonary disease: A case report

Tuberculosis and Respiratory Diseases

Volumn 54, Issue 6, 2003, Pages 621-627

  Koh, Won Jung ^a   Kwon, O Jung ^a   Kang, Eun Hae ^a   Suh, Gee Young ^a   Chung, Man Pyo ^a   Kim, Hojoong ^a   Kim, Kwhanmien ^a   Lee, Nam Yong ^a   Han, Joungho ^a   Kim, Tae Sung ^a   Lee, Kyung Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Atypical mycobacteria; Korea; Lung diseases; Mycobacterium avium complex; Thoracic surgery

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; CASE REPORT; ERADICATION THERAPY; HUMAN; KOREA; LUNG DISEASE; LUNG RESECTION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0141737745     PISSN: 03780066     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2003.54.6.621     Document Type: Article

References (15)

1. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-25.
2. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999. Thorax 2000;55:210-8.
3. Koh WJ, Kwon OJ, Lee KS. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol 2002;3:145-57.
4. Dautzenberg B, Piperno D, Diot P, Truffot-Pernot C, Chauvin JP. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Chest 1995;107:1035-40.
5. Wallace RJ Jr., Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium auium complex. The first 50 patients. Am J Respir Crit Care Med 1996;153:1766-72.
6. Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H, Niimi A, et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999;160:866-72.
7. Huang JH, Kao PN, Adi V, Ruoss SJ. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 1999;115:1033-40.
8. Nelson KG, Griffith DE, Brown BA, Wallace RJ Jr. Results of operation in Mycobacterium avium-intracellulare lung disease. Ann Thorac Surg 1998;66:325-30.
9. Shiraishi Y, Nakajima Y, Takasuna K, Hanaoka T, Katsuragi N, Konno H. Surgery for Mycobacterium avium complex lung disease in the clarithromycin era. Eur J Cardiothorac Surg 2002;21:314-8.
10. Dutt AK, Stead WW. Long-term results of medical treatment in Mycobacterium intracellulare infection. Am J Med 1979;67:449-53.
11. Rosenzweig DY. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases. Chest 1979;75:115-9.
12. Hunter AM, Campbell IA, Jenkins PA, Smith AP. Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax 1981;36:326-9.
13. Research Committee of the British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardized treatment. Int J Tuberc Lung Dis 2002;6:628-34.
14. Moran JF, Alexander LG, Staub EW, Young WG Jr., Sealy WC. Long-term results of pulmonary resection for atypical mycobacterial disease. Ann Thorac Surg 1983;35:597-604.
15. Corpe RF. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. Rev Infect Dis 1981;3:1064-7.